- Home
- PDLB vs EIKN Comparison
PDLB vs EIKN Comparison
Compare PDLB & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDLB | EIKN |
|---|---|---|
| Founded | 1960 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.0M | 401.9M |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | PDLB | EIKN |
|---|---|---|
| Price | $20.15 | $8.06 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $24.33 |
| AVG Volume (30 Days) | 73.4K | ★ 505.1K |
| Earning Date | 11-03-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 160.87 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $28.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.91 | $6.45 |
| 52 Week High | $21.10 | $16.50 |
Technical Indicators
Market Signals| Indicator | PDLB | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 49.05 |
| Support Level | $20.11 | $7.96 |
| Resistance Level | $20.70 | $10.20 |
| Average True Range (ATR) | 0.28 | 0.59 |
| MACD | 0.00 | 0.17 |
| Stochastic Oscillator | 46.03 | 77.05 |
Price Performance
Historical ComparisonAbout PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.